APOD and Parkinson disease: Integrated biomarker set accuracy can also be further improved by incorporating markers from other generalist and specific pathways that represent the same trend of changes in CSF and/or serum as those seen in the PD brain such as 3-hydroxykynurenine [94,95], apolipoprotein D [96,97] and potentially neurofilament light chain [98].